274 related articles for article (PubMed ID: 11396201)
1. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.
Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY
Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201
[TBL] [Abstract][Full Text] [Related]
2. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
Zang T; Sun F; Li Y
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
Wang W; Bergh A; Damber JE
Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
[TBL] [Abstract][Full Text] [Related]
4. The relationship between angiogenesis and cyclooxygenase-2 expression in prostate cancer.
Mukherjee R; Edwards J; Underwood MA; Bartlett JM
BJU Int; 2005 Jul; 96(1):62-6. PubMed ID: 15963122
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 in prostate carcinoma.
Yoshimura R; Sano H; Masuda C; Kawamura M; Tsubouchi Y; Chargui J; Yoshimura N; Hla T; Wada S
Cancer; 2000 Aug; 89(3):589-96. PubMed ID: 10931458
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.
König JE; Senge T; Allhoff EP; König W
Prostate; 2004 Feb; 58(2):121-9. PubMed ID: 14716737
[TBL] [Abstract][Full Text] [Related]
7. [Expression of cyclooxygenase-2 and vascular endothelial growth factor in human prostate cancer and its significance].
Jin TX; Li XG; Wu WY; Piao DM; Feng JY; Sang J
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):207-10. PubMed ID: 16597032
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression.
Tanji N; Kikugawa T; Yokoyama M
Anticancer Res; 2000; 20(4):2313-9. PubMed ID: 10953290
[TBL] [Abstract][Full Text] [Related]
9. Resistance of prostate cancer cell lines to COX-2 inhibitor treatment.
Wagner M; Loos J; Weksler N; Gantner M; Corless CL; Barry JM; Beer TM; Garzotto M
Biochem Biophys Res Commun; 2005 Jul; 332(3):800-7. PubMed ID: 15907789
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer.
Wang W; Bergh A; Damber JE
Clin Cancer Res; 2005 May; 11(9):3250-6. PubMed ID: 15867220
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
Takigawa N; Ida M; Segawa Y; Nakata M; Mandai K; Kishino D; Fujiwara K; Saeki H; Takashima S; Eguchi K
Anticancer Res; 2003; 23(6D):5069-73. PubMed ID: 14981968
[TBL] [Abstract][Full Text] [Related]
12. [Prostate carcinoma: higher COX-2 contents in advanced tumors].
Weiss J; Friedrich MG
Aktuelle Urol; 2004 Sep; 35(5):359-61. PubMed ID: 15383996
[No Abstract] [Full Text] [Related]
13. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB
Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373
[TBL] [Abstract][Full Text] [Related]
14. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 in human gastric carcinoma.
Ristimäki A; Honkanen N; Jänkälä H; Sipponen P; Härkönen M
Cancer Res; 1997 Apr; 57(7):1276-80. PubMed ID: 9102213
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
[TBL] [Abstract][Full Text] [Related]
18. [Detection of telomerase activity in prostate needle-biopsy samples].
Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]